ArticleImmunoTargets and therapy2026

Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study.

Yingying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.